Literature DB >> 7713927

Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide.

D Muriaux1, P M Girard, B Bonnet-Mathonière, J Paoletti.   

Abstract

Genomic human immunodeficiency virus type 1 (HIV-1) RNA consists of two identical RNA molecules joined noncovalently near their 5' ends in a region called the dimer linkage structure (DLS). Previous work has shown that the putative DLS is localized in a 113-nucleotide domain encompassing the 5' end of the gag gene. This region contains conserved purine tracks that are thought to mediate dimerization through purine quartets. However, recently, an HIV-1Mal RNA dimerization model was proposed as the HIV-1Mal RNA dimerization initiation site, involving another region upstream from the splice donor site and possibly confined within a stem-loop. In the present study, we have investigated the dimerization of HIV-1Lai RNA, using in vitro dimerization assays under conditions of low ionic strength, predictive RNA secondary structures determined by computer folding, and antisense DNA oligonucleotides in order to discriminate between these two models. Our results suggest that purine quartets are not involved in the dimer structure of HIV-1Lai RNA and have led to the identification of a region upstream from the splice donor site. This region, comprising an autocomplementary sequence in a possible stem-loop structure, is responsible for the formation of dimeric HIV-1Lai RNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713927     DOI: 10.1074/jbc.270.14.8209

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding.

Authors:  F Jossinet; J C Paillart; E Westhof; T Hermann; E Skripkin; J S Lodmell; C Ehresmann; B Ehresmann; R Marquet
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.

Authors:  J Sakuragi ; T Shioda; A T Panganiban
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Two alternating structures of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

5.  Modeling the dynamics of a mutated stem-loop in the SL1 domain of HIV-1Lai genomic RNA by 1H-NOESY spectra.

Authors:  S Fausti; G La Penna; J Paoletti; D Genest; G Lancelot; A Perico
Journal:  J Biomol NMR       Date:  2001-08       Impact factor: 2.835

6.  Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro.

Authors:  Jean-Marc Lanchy; Casey A Rentz; John D Ivanovitch; J Stephen Lodmell
Journal:  Biochemistry       Date:  2003-03-11       Impact factor: 3.162

7.  Functional characterization of the dimer linkage structure RNA of Moloney murine sarcoma virus.

Authors:  H Ly; D P Nierlich; J C Olsen; A H Kaplan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA.

Authors:  Jean-Marc Lanchy; John D Ivanovitch; J Stephen Lodmell
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

9.  A human immunodeficiency virus type 1-infected individual with low viral load harbors a virus variant that exhibits an in vitro RNA dimerization defect.

Authors:  Hendrik Huthoff; Atze T Das; Monique Vink; Bep Klaver; Fokla Zorgdrager; Marion Cornelissen; Ben Berkhout
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity.

Authors:  J L Clever; R A Taplitz; M A Lochrie; B Polisky; T G Parslow
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.